Literature DB >> 25212688

Use of animal models in elucidating disease pathogenesis in IBD.

Puja Vora Khanna1, David Quan Shih, Talin Haritunians, Dermot Patrick McGovern, Stephan Targan.   

Abstract

Inflammatory bowel diseases (IBD) are a collection of diseases characterized by chronic gastrointestinal inflammation resulting from an exuberant immune response to commensal flora in genetically susceptible individuals. Rapid advances in the field of genomics have resulted in the identification of at least 163 loci that contribute susceptibility to both Crohn's disease (CD) and ulcerative colitis (UC). Similar to other complex diseases, however, the "curse of missing heritability" remains a significant concern in understanding the mechanisms underlying IBD. While genetic discoveries, to date, only account for 7-14% of disease variance for IBD, studies have increasingly demonstrated a role for environmental factors in disease pathogenesis. Furthermore, the use of animal models of IBD has led to a greater understanding of disease pathogenesis implicating various aspects of the innate immune response including the bacterial, fungal, and viral microbiome and adaptive immune response such as the interleukin (IL)-23/IL-17 pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25212688      PMCID: PMC4205729          DOI: 10.1007/s00281-014-0444-6

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  100 in total

1.  The human microbiome project.

Authors:  Peter J Turnbaugh; Ruth E Ley; Micah Hamady; Claire M Fraser-Liggett; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

Review 2.  TH17 cells in development: an updated view of their molecular identity and genetic programming.

Authors:  Chen Dong
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

Review 3.  Induction and effector functions of T(H)17 cells.

Authors:  Estelle Bettelli; Thomas Korn; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nature       Date:  2008-06-19       Impact factor: 49.962

4.  Fungi and inflammatory bowel diseases: Alterations of composition and diversity.

Authors:  Stephan J Ott; Tanja Kühbacher; Meike Musfeldt; Philip Rosenstiel; Stephan Hellmig; Ateequr Rehman; Oliver Drews; Wilko Weichert; Kenneth N Timmis; Stefan Schreiber
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

5.  Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Authors:  Kim A Papp; Richard G Langley; Mark Lebwohl; Gerald G Krueger; Philippe Szapary; Newman Yeilding; Cynthia Guzzo; Ming-Chun Hsu; Yuhua Wang; Shu Li; Lisa T Dooley; Kristian Reich
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

6.  Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.

Authors:  Alexandra Zhernakova; Eleanora M Festen; Lude Franke; Gosia Trynka; Cleo C van Diemen; Alienke J Monsuur; Marianna Bevova; Rian M Nijmeijer; Ruben van 't Slot; Roel Heijmans; H Marike Boezen; David A van Heel; Adriaan A van Bodegraven; Pieter C F Stokkers; Cisca Wijmenga; J Bart A Crusius; Rinse K Weersma
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

7.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

8.  Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.

Authors:  Julia Seiderer; Ira Elben; Julia Diegelmann; Jürgen Glas; Johannes Stallhofer; Cornelia Tillack; Simone Pfennig; Matthias Jürgens; Silke Schmechel; Astrid Konrad; Burkhard Göke; Thomas Ochsenkühn; Bertram Müller-Myhsok; Peter Lohse; Stephan Brand
Journal:  Inflamm Bowel Dis       Date:  2008-04       Impact factor: 5.325

9.  Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.

Authors:  Miles Parkes; Jeffrey C Barrett; Natalie J Prescott; Mark Tremelling; Carl A Anderson; Sheila A Fisher; Roland G Roberts; Elaine R Nimmo; Fraser R Cummings; Dianne Soars; Hazel Drummond; Charlie W Lees; Saud A Khawaja; Richard Bagnall; Denis A Burke; Catherine E Todhunter; Tariq Ahmad; Clive M Onnie; Wendy McArdle; David Strachan; Graeme Bethel; Claire Bryan; Cathryn M Lewis; Panos Deloukas; Alastair Forbes; Jeremy Sanderson; Derek P Jewell; Jack Satsangi; John C Mansfield; Lon Cardon; Christopher G Mathew
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

Review 10.  An ecological and evolutionary perspective on human-microbe mutualism and disease.

Authors:  Les Dethlefsen; Margaret McFall-Ngai; David A Relman
Journal:  Nature       Date:  2007-10-18       Impact factor: 69.504

View more
  11 in total

Review 1.  Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.

Authors:  Noam Jacob; Stephan R Targan; David Q Shih
Journal:  United European Gastroenterol J       Date:  2016-05-10       Impact factor: 4.623

2.  CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis.

Authors:  J Brasseit; E Althaus-Steiner; M Faderl; N Dickgreber; L Saurer; V Genitsch; T Dolowschiak; H Li; D Finke; W-D Hardt; K D McCoy; A J Macpherson; N Corazza; M Noti; C Mueller
Journal:  Mucosal Immunol       Date:  2015-09-16       Impact factor: 7.313

3.  Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease.

Authors:  Hua Fan; Juan Du; Xia Liu; Wei-Wei Zheng; Ze-Hao Zhuang; Cheng-Dang Wang; Rui Gao
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

4.  Mouse Model of Reversible Intestinal Inflammation.

Authors:  Cheong Kc Kwong Chung; Jennifer Brasseit; Esther Althaus-Steiner; Silvia Rihs; Christoph Mueller
Journal:  Bio Protoc       Date:  2017-03-20

Review 5.  Spontaneous and transgenic rodent models of inflammatory bowel disease.

Authors:  Susan Prattis; Abdo Jurjus
Journal:  Lab Anim Res       Date:  2015-06-26

6.  Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects.

Authors:  Kasper Vadstrup; Elisabeth Douglas Galsgaard; Jens Gerwien; Marianne Kajbæk Vester-Andersen; Julie Steen Pedersen; Julie Rasmussen; Søren Neermark; Marianne Kiszka-Kanowitz; Teis Jensen; Flemming Bendtsen
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

7.  TNFα deficiency results in increased IL-1β in an early onset of spontaneous murine colitis.

Authors:  S De Santis; D Kunde; V Galleggiante; M Liso; L Scandiffio; G Serino; A Pinto; P Campiglia; R Sorrentino; E Cavalcanti; A Santino; M L Caruso; R Eri; M Chieppa
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

8.  Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats.

Authors:  Hong Mi; Feng-Bin Liu; Hai-Wen Li; Jiang-Tao Hou; Pei-Wu Li
Journal:  BMC Complement Altern Med       Date:  2017-06-15       Impact factor: 3.659

9.  Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota.

Authors:  Chen Diling; Yang Xin; Zheng Chaoqun; Yang Jian; Tang Xiaocui; Chen Jun; Shuai Ou; Xie Yizhen
Journal:  Oncotarget       Date:  2017-09-06

10.  A vitamin D receptor agonist converts CD4+ T cells to Foxp3+ regulatory T cells in patients with ulcerative colitis.

Authors:  Dong Lu; Bin Lan; Zonren Din; Hang Chen; Guoqiang Chen
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.